Hudson Bay Capital Management LP Pliant Therapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 57,500 shares of PLRX stock, worth $90,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,500
Previous 100,000
42.5%
Holding current value
$90,850
Previous $1.12 Million
32.47%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
64.8MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$9.44 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.86 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$7.32 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$5.1 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$5.05 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $76.9M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...